Related Experiment Video
Updated: May 17, 2026

10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
[Group A streptococcal meningitis]
Z Jouhadi1, H Sadiki, M Lehlimi
1Service de Maladies Infectieuses Pédiatriques, Hôpital d'Enfants, Casablanca, Maroc.
Medecine Et Maladies Infectieuses
|October 30, 2012
Summary
Group A Streptococcus (GAS) meningitis is rare but serious in children. While often treatable, this invasive bacterial infection can be fatal, even in those without prior health issues.
Area of Science:
- Infectious Diseases
- Pediatrics
- Microbiology
Context:
- Invasive group A Streptococcus (GAS) infections show increasing incidence and severity.
- GAS meningitis is an uncommon but significant pediatric infection.
- Understanding GAS meningitis is crucial for effective treatment and prognosis.
Purpose:
- To analyze clinical and biological data of pediatric GAS meningitis.
- To report 10 new cases and review existing literature on GAS meningitis.
- To identify risk factors and outcomes associated with GAS meningitis.
Summary:
- The study analyzed 10 pediatric GAS meningitis cases (mean age 3 years; 70% female).
- Five patients had pre-existing or concurrent community-acquired infections.
- Two fatalities occurred; treatment involved cephalosporins and amoxicillin.
Impact:
- Highlights the potential severity of GAS meningitis, including fatal outcomes.
- Emphasizes that even children without risk factors can experience severe infection.
- Informs clinical management and prognosis for pediatric GAS meningitis.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
